Functional consequences of interleukin 2 receptor expression on resting human lymphocytes: Identification of a novel natural killer cell subset with high affinity receptors

Journal of Experimental Medicine

Volumn 171, Issue 5, 1990, Pages 1509-1526

  Caligiuri, Michael A ^a,d   Zmuidzinas, Antanina ^b   Manley, Thomas J ^a   Levine, Herbert ^a   Smith, Kendall A ^c   Ritz, Jerome ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Department of Biochemistry ^*  (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

^d ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; RADIOISOTOPE;

ARTICLE; CELL CULTURE; HUMAN; HUMAN CELL; LYMPHOCYTE SUBPOPULATION; NATURAL KILLER CELL; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD; BLOTTING, NORTHERN; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; INTERLEUKIN-2; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; NUCLEIC ACID HYBRIDIZATION; RECEPTORS, INTERLEUKIN-2; RNA; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025289835     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.171.5.1509     Document Type: Article

References (52)

1. Smith, K. A. 1989. The interleukin 2 receptor. Annu. Rev. Cell Biol. 5:397.
2. Henney, C. S., K. Kuribayashi, D. E. Kern, and S. Gillis. 1981. Interleukin-2 augments natural killer cell activity. Nature (Lond.). 291:335.
3. Domzig, W., B. M. Stadler, and R. B. Herberman. 1983. Interleukin 2 dependence of human natural killer (NK) cell activity. J. Immunol. 130:1970.
4. Trinchieri, G., M. Matsumoto-Kobayashi, S. C. Clark, J. Seehra, L. London, and B. Perussia. 1984. Response to resting human peripheral blood natural killer cells to interleukin 2. J. Exp. Med. 160:1147.
5. Mule, J. J., J. Yang, S. Shu, and S. A. Rosenberg. 1986. The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin-2 in vivo: direct correlation between reduction of established metastases and cytolytic activity of lymphokine-activated killer cells. J. Immunol. 136:3899.
6. Rosenberg, S. A., M. T. Lotze, L. M. Muul, A. E. Chang, F. P. Avis, S. Leitman, W. M. Linehan, C. N. Robertson, R. E. Lee, J. T. Rubin, C. A. Seipp, C. G. Simpson, and D. E. White. 1987. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high dose interleukin-2 alone. N. Engl. J. Med. 316:889.
7. Lê Thi Bich-Thuy, H. C. Lane, and A. S. Fauci. 1984. Proliferation of in vitro unstimulated human B and T lymphocytes to recombinant IL-2. Lymph. Res. 3:229.
8. Tsudo, M., R. W. Kozak, C. K. Goldman, and T. A. Waldmann. 1986. Demonstration of a non-Tac peptide that binds interleukin 2: a potential participant in a multichain interleukin 2 receptor complex. Proc. Natl. Acad. Set. USA. 83:9694.
9. Teshigawara, K., H.-M. Wang, K. Kato, and K. A. Smith. 1987. Interleukin 2 high affinity receptor expression requires two distinct binding proteins. J. Exp. Med. 165:223.
10. Tsudo, M., C. K. Goldman, K. F. Bongiovanni, W. C. Chan, E. F. Winton, M. Yagita, E. A. Grimm, and T. A. Waldmann. 1987. The p75 peptide is the receptor for interleukin 2 expressed on large granular lymphocytes and is responsible for the interleukin 2 activation of these cells. Proc. Natl. Acad. Sci. USA. 84:5394.
11. Siegel, J. P., M. Sharon, P. L. Smith, and W.J. Leonard. 1987. The IL-2 receptor β chain (p70): role in Mediating Signals for LAK, NK, and proliferative activities. Science (Wash. DC). 238:75.
12. Dukovich, M., Y. Wano, Le thy Bich-Thuy, P. Katz, B. R. Cullin, J. H. Kehrl, and W. C. Greene. 1987. Identification of a second human interleukin-2 binding protein and its role in the assembly of the high affinity IL-2 receptor. Nature (Land.). 327:518.
13. Nikaido, T., A. Shimizu, N. Ishida, H. Sabe, K. Teshigawara, M. Maeda, T. Uchiyama, J. Yodoi, and T. Honjo. 1984. Molecular cloning of cDNA encoding human interleukin-2 receptor. Nature (Land.). 311:631.
14. Leonard, W. J., J. M. Depper, G. R. Crabtree, S. Rudikoff, J. Pumphrey, R.J. Robb, M. Krunke, P. B. Svetlik, N.J. Peffer, T. A. Waldmann, and W. C. Greene. 1984. Molecular cloning and expression of cDNAs for the human interleukin-2 receptor. Nature (Lond). 311:626.
15. Cosman, D., D. P. Ceretti, A. Larsen, L. Park, C. March, S. Dower, S. Gillis, and D. Urdal. 1984. Cloning, sequence and expression of human interleukin-2 receptor. Nature (Lond). 312:768.
16. Hatakeyama, M., M. Tsudo, S. Minamoto, T. Kono, T. Doi, T. Miyata, M. Miyasaka, and T. Taniguchi. 1989. Interleukin 2 receptor β chain gene: generation of three receptor forms by cloned human α and β chain cDNAs. Science (Wash. DC). 244:551.
17. Wang, H.-M., and K. A. Smith. 1987. The interleukin 2 receptor. Functional consequences of its bimolecular structure. J. Exp. Med. 166:1055.
18. Takeshita, T, Y. Goto, K. Tada, K. Nagata, H. Asao, and K. Sugamura. 1989. Monoclonal antibody defining a molecule possibly identical to the p75 subunit of interleukin 99 2 receptor. J. Exp. Med. 169:1323.
19. Tsudo, M., F. Kitamura, and M. Miyasaka. 1989. Characterization of the interleukin 2 receptor β chain using three distinct monoclonal antibodies. Proc. Natl. Acad. Sci. USA. 86:1882.
20. Theile, D. L., and P. E. Lipsky. 1985. Regulation of cellular function by products of lysosomal enzyme activity: elimination of human natural killer cells by a dipeptide methyl ester generated from L-leucine methyl ester by monocytes or polymorphonuclear leukocytes. Proc. Natl. Acad. Sci. USA. 82:2472.
21. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl, editors. 1987. In Current Protocols In Molecular Biology. John Wiley and Sons, New York. 4.1.2-4.1.6.
22. Feinberg, A. P., and B. Vogelstein. 1983. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132:6.
23. Phillips, J. H., T. Takeshita, K. Sugamura, and L. L. Lanier. 1989. Activation of natural killer cells via the p75 interleukin 2 receptor. J. Exp. Med. 170:291.
24. Romain, P. L., and S. F. Schlossman. 1984. Human T lymphocyte subsets. Functional heterogeneity and surface recognition structures. J. Clin. Invest. 74:1559.
25. "dim"+ lymphokine-activated killer cells. J. Immunol. 142:2949.
26. − populations. J. Immunol. 134:330.
27. Caligiuri, M., C. Murray, D. Buchwald, H. Levine, R Cheney, D. Peterson, A. L. Komaroff, and J. Ritz. 1987. Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome. J. Immunol. 139:3306.
28. Lê Thi Bich-Thuy, M. Dukovich, N. J. Peffer, A. S. Fauci, J. H. Kehrl, and W. C. Greene. 1987. Direct activation of human resting T cells by IL 2: the role of an IL 2 receptor distinct from the TAC protein. J. Immunol. 139:1550.
29. Lanier, L. L., A. M. Le, C. I. Civin, M. R. Loken, and J. H. Phillips. 1986. The relationship of CD16 (Leu 11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic lymphocytes. J. Immunol. 136:4480.
30. Ben Aribia, M. H., N. Moire, D. Metivier, C. Vaquero, O. Lantz, D. Olive, B. Charpentier, and A. Senik. 1989. IL-2 receptors on circulating natural killer cells and T lymphocytes. Similarity in number and affinity but difference in transmission of the proliferation signal. J. Immunol. 142:490.
31. Yagita, H., M. Nakata, A. Azuma, T. Nitta, T. Takeshita, K. Sugamura, and K. Okumura. 1989. Activation of peripheral blood T cells via the p75 interleukin 2 receptor. J. Exp. Med. 170:1445.
32. Lê Thi Bich-Thuy, H. C. Lane, and A. S. Fauci. 1986. Recombinant interleukin-2-induced polyclonal proliferation of in vitro unstimulated human peripheral blood lymphocytes. Cell. Immunol. 98:396.
33. Harel-Bellan, A., J. Bertoglio, A. Quillet, C. Marchiol, H. Wakasugi, Z. Mishall, and D. Fradelizi. 1986. Interleukin 2 (IL-2) up-regulates its own receptor on a subset of human unprimed peripheral blood lymphocytes and triggers their proliferation. J. Immunol. 136:2463.
34. London, L., B. Perussia, and G. Trinchieri. 1986. Induction of proliferation in vitro of resting human natural killer cells: IL-2 induces into cell cycle most peripheral blood NK cells, but only a minor subset of low density T cells. J. Immunol. 137:3845.
35. Talmadge, J. E., R. H. Wiltrout, D. F. Counts, R. B. Herberman, T. McDonald, and J. R. Ortaldo. 1986. Proliferatio n of human peripheral blood lymphocytes induced by recombinant human interleukin 2: contribution of large granular lymphocytes and T " lymphocytes. Cell. Immunol. 102:261.
36. Uchiyama, T, S. Broder, and T. A. Waldmann. 1981. A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells. J. Immunol. 126:1393.
37. Ortaldo, J. R., T. Mason, J. P. Gerald, L. E. Henderson, W. Farrar, R. F. Hopkins III, R. B. Herberman, and H. Rabin. 1984. Effect of natural killer cell activity: lack of involvement of the Tac antigen for these immunoregulatory effects. J. Immunol. 133:779.
38. Lanier, L. L., C. J. Benike, J. H. Phillips, and E. G. Engleman. 1985. Recombinant interleukin 2 enhanced natural killer cell-mediated cytotoxicity in human lymphocyte subpopulations expressing the Leu 7 and Leu 11 antigens. J. Immunol. 134:794.
39. Kehrl, J. H., M. Dukovich, G. Whalen, P. Katz, A. S. Fauci, and W. C. Greene. 1988. Novel interleukin 2 (IL-2) receptor appears to mediate IL-2-induced activation of natural killer cells. J. Clin. Invest. 81:200.
40. Meuer, S. C, R. E. Hussey, D. A. Cantrell, J. C. Hodgdon, S. F. Schlossman, K. A. Smith, and E. L. Reinherz. 1984. Triggering of the T3-Ti antigen receptor complex results in clonal T cell proliferation through an interleukin 2 dependent autocrine pathway. Proc. Natl. Acad. Sci. USA. 81:1509.
41. Cantrell, D. A., and K. A. Smith. 1983. Transient expression of interleukin-2 receptors: consequences for T-cell growth. J. Exp. Med. 158:1895.
42. Welsh, R. M. 1978. Cytotoxic cells induced during lymphocytic choriomeningitis virus infection of mice. I. Characterization of natural killer cell induction. J. Exp. Med. 148:163.
43. Biron, C. A., and Welsh, R. M. 1982. Blastogenesis of natural killer cells during viral infection in vivo. J. Immunol. 129:2788.
44. Biron, C. A., L. R. Turgiss, and R. M. Welsh. 1983. Increase in NK cell number and turnover rate during acute viral infection. J. Immunol. 131:1539.
45. Bukowski, J. F., J. F. Warner, G. Dennert, and R. M. Welsh. 1985. Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo. J. Exp. Med. 161:40.
46. Welsh, R. M. Regulation of virus infections by natural killer cells. 1986. Nat. Immun. Cell Growth Regul. 5:169.
47. Biron, C. A., K. S. Byron, and J. L. Sullivan. 1989. Severe herpesvirus infections in an adolescent without natural killer cells. N. Engl. J. Med. 320:1731.
48. Ritz, J., T. J. Campen, R. E. Schmidt, H. D. Royer, T. Hercend, R. E. Hussey, and E. L. Reinherz. 1985. Analysis of T-cell receptor gene rearrangement and expression in human natural killer clones. Science (Wash. DC). 228:1540.
49. Anderson, P., M, Caligiuri, J. Ritz, and S. F. Schlossman. 1989. CD3-negative natural killer cells express TCR-ζ as part of a novel molecular complex. Nature (Lond.). 341:159.
50. Janeway, C. A. 1989. A primitive immune system. Nature (Lond.). 341:108.
51. + cells in cancer patients receiving recombinant interleukin-2. Cancer Res. 48:6597.
52. Phillips, J. H., B. T. Gemlo, W. W. Myers, A. A. Rayner, and L. L. Lanier. 1987. In vivo and in vitro activation of natural killer cells in advanced cancer patients undergoing combined recombinant interleukin-2 and LAK cell therapy. J. Clin. Oncol. 5:1933.